Supemtek® influenza vaccine gains approval in European Union
Category: #health  By Pankaj Singh  Date: 2020-11-20
  • share
  • Twitter
  • Facebook
  • LinkedIn

Supemtek® influenza vaccine gains approval in European Union

The European Commission has recently approved the authorization for commercialization of Supemtek®, a quadrivalent recombinant technology-based influenza vaccine, designed for preventing influenza among adults in the age group of 18 years and above. According to credible sources, Supemtek is the first ever recombinant influenza vaccine to receive approval in the European Union. Also, the first launch in Europe is expected in influenza season 2022/2023, with a possibility of increasing the availability of doses as soon as the 2021/2022 season in certain nations.

The authorization is apparently based on a clinical data showing safety, efficacy and immunogenicity of Supemtek in two Phase 3 randomized controlled trials conducted on over 10,000 patients. And the relative efficacy of Supemtek in particular was demonstrated in a Phase 3 multicenter randomized controlled efficacy trial.

Every year, apparently 290,000 to 650,000 people globally, die due to influenza. The burden on hospitals is recorded as nearly 10 million influenza-related hospitalizations. Based on a recent data, influenza tends to increase the risk of heart attack by up to 10 times, whereas the risk of stroke by up to 8 times, in the week post influenza infection indicating the fact that the severity of influenza is beyond its typical respiratory complications.

Speaking on the matter, Head of Sanofi Pasteur, Thomas Triomphe has stated that in view of coronavirus pandemic, prevention of influenza continues to be a public health priority and they consider the Supemtek approval as a strong factor supporting their commitment of enhancing influenza vaccine technology. Through Supemtek, they intend to provide European health authorities with an innovative solution which has demonstrated improved ability to mitigate influenza, its severe complications and its burden on healthcare systems

For the records, Supemtek is developed using recombinant technology, which provides exact match to the key component of influenza strains recommended by the WHO avoiding viral mutation risk. Further, Supemtek consists of three times more antigen than the egg-based and cell-based vaccines. It has been claimed that application of increased amount of antigen in conjunction with recombinant technology provides better protection against influenza, specifically for patients in age group of 50 and above.

Source credits: https://www.globenewswire.com/news-release/2020/11/18/2129521/0/en/European-Commission-approves-Supemtek-quadrivalent-recombinant-influenza-vaccine-for-the-prevention-of-influenza-in-adults-aged-18-years-and-older.html



About Author

Pankaj Singh

Email: [email protected]   

Pankaj Singh

Pankaj Singh Develops content for Market Size Forecasters, Algosonline, and a couple of other platforms. A Post Graduate in Management by qualification, he worked as an underwriter in the UK insurance domain before deciding to switch his field of profession. With exp...

Read More

More News By Pankaj Singh

Canada-based CloudMD buys CMD to expand medical database
Canada-based CloudMD buys CMD to expand medical database
By Pankaj Singh

CloudMD Software & Services Inc., a virtual medical care solutions provider based in Canada, has reportedly announced that it has completed the acquisition of the Canadian Medical Directory (CMD)- the nation’...

Collier’s Medical to offer HealthySole UVC units for infection control
Collier’s Medical to offer HealthySole UVC units for infection control
By Pankaj Singh

Collier’s Medical Equipment, a leading distributor of technologically-advanced medical equipment, has reportedly inked an agreement with HealthySole. This agreement has been geared towards the delivery of Healthy...

Western Union to offer money transfer services at Walmart U.S. stores
Western Union to offer money transfer services at Walmart U.S. stores
By Pankaj Singh

Walmart, an American retail chain, and Western Union, a financial service company, have recently announced a new collaboration deal. The agreement will allow the money transfer services of Western Union to be deployed ...